Cordlife Group Limited (CLIFF)

Other OTC - Other OTC Delayed Price. Currency in USD

Add to watchlist

0.2600

0.0000

(0.00%)

As of 09:30AM EDT. Market open.

Advertisement

Full screen

Trade prices are not sourced from all markets

Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies

Chart Events

Neutralpattern detected

View all chart patterns

Performance Outlook

Previous Close	0.2600
Open	0.2600
Bid	N/A x N/A
Ask	N/A x N/A
Day's Range	0.2600 - 0.2600
52 Week Range	0.2600 - 0.3176
Volume	500
Avg. Volume	0

Market Cap	66.81M
Beta (5Y Monthly)	0.74
PE Ratio (TTM)	13.00
EPS (TTM)	0.0200
Earnings Date	N/A
Forward Dividend & Yield	0.01 (2.52%)
Ex-Dividend Date	May 06, 2022
1y Target Est	N/A

Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.

Fair Value

XX.XX

N/A

Subscribe to Yahoo Finance Plus to view Fair Value for CLIFF

View details

Research that delivers an independent perspective, consistent methodology and actionable insight

Related Research

CORDLIFE GROUP LIMITED
Analyst Report: Pfizer Inc.Pfizer is one of the world's largest pharmaceutical firms, with annual sales close to $50 billion (excluding COVID-19 vaccine sales). While it historically sold many types of healthcare products and chemicals, now, prescription drugs and vaccines account for the majority of sales. Top sellers include pneumococcal vaccine Prevnar 13, cancer drug Ibrance, cardiovascular treatment Eliquis, and immunology drug Xeljanz. Pfizer sells these products globally, with international sales representing close to 50% of its total sales. Within international sales, emerging markets are a major contributor.
Rating
Fair Value
Economic Moat
5 months agoMorningstar